Fortbildung > 4th Swiss Autoimmune Liver Disease Meeting 21.09.2023 09:00 - 22.09.2023 17:20 2 Credits USI Università della Svizzera Italiana, Aula Magna Bia Giuseppe Buffi 13 6900 Lugano Anmeldung und Informationen Programm USI Università della Svizzera Italiana, Aula Magna Bia Giuseppe Buffi 13 6900 Lugano Anmeldung und Informationen 1 4th Swiss Autoimmune Liver Disease Meeting September 21 st- 22 nd 2023 , USI Università della Sv izzera Italiana, Aula Magna, Lugano, Switzerland September 21 st Patients’ session 9:00 – 10:30 – Pregnancy – Michael Heneghan – Drug s ide effects – Maria Isabel Lucena and Raul Andrade – New therapies – Michael Manns Invited: – SwissHePa – UK PBC Foundation – AMAF – TBC – Deutsche Leberhilfe – British Liver Trust – TBC – Globalliver 11:00 – 11:15 Welcome Benedetta Terziroli Beretta -Piccoli and Andrea De Gottardi Welcome from Università della Svizzera Italiana – Giovanni Pedrazzini Basic science session s 1. Genetics 11: 15 -12: 55 – Chairs: G ideon Hirschfield and Federica Sallusto 11: 15 – 11: 35 Genetics of PBC – Pietro Invernizzi 11: 35 – 11: 55 Genetics of PSC – Tom Karlsen 11: 55 – 12: 15 Genetics of AIH – Ynto de Boer 12: 15 – 12: 35 Inherited immune deficiencies and autoimmunity – Mike Recher 12: 35 – 12:55 Discussion 2 12: 55 – 13: 45 Lunch 2. Hot topics in autoimmune liver diseases 13:45 -16:40 – Chairs: Michael Manns and Michael Trauner 13:45 – 14:05 Cellular therapies – Maria Serena Longhi 14:05 – 14:25 SARS -CoV -2 and liver autoimmunity – Gideon Hirschfield 14:25 – 14:45 Pregnancy in autoimmune liver diseases patients – Michael Heneghan 14:45 – 15:05 Drug -induced AIH -like DILI – Maribel Lucena 15:05 – 15:25 Discussion 15:25 – 16:00 Coffee break 3. Oral presentations – 16:00 – 17:0 0 – Chairs: Michael Heneghan and Giorgina Mieli -Vergani 16:00 – 16:15 Oral presentation 1 16:15 – 16:30 Oral presentation 2 16:30 – 16 :45 Oral presentation 3 16: 4 5 – 17:00 Oral presentation 4 4. Mechanisms of autoimmunity 1 7:0 0-18:20 – Chairs: Diego Vergani and Andreas Cerny 17:00 – 17:20 The Long and Latent Road to Autoimmunity – Eric Gershwin 17:20 – 17:40 T cells in autoimmunity – Federica Sallusto 17:40 – 18:00 Viruses and autoimmunity – Christian M ünz 18:0 0 – 18:20 Discussion 18:20 – End of first day 3 September 2 2nd Clinical session 1. Diagnostic dilemmas 08:30 -10:00 – Chairs: Andrea De Gottardi and Andrea s Kremer 8: 30 – 8:45 Radiological c linical case presentation : the diagnosis of PSC – Stefano Cappio and his fellow 8:45 – 9:05 Imaging in PSC and ASC – Annamaria Deganell o 9:05 – 9:20 Serological case presentation : the diagnosis of AIH – Eric Dayer and Benedetta Terziroli Beretta -Piccoli 9:20 – 9:40 Are autoantibodies still useful in the AI era? – Diego Vergani 9:40 – 10:00 Discussion 10:00 – 10: 30 Coffe e break 2. Treatment 10:30 – 11:50 – Chairs: Andreas Kremer and Raul Andrade 10:30 – 10:50 Novel therapeutic targets for autoimmune cholestatic liver diseases – Michael Trauner 10:50 – 11:10 Treatment of cholestatic pruritus – Andreas Kremer 11:10 – 11:30 Difficult to treat AIH patients – Ansgar Lohse 11:30 – 11:50 Discussion Oral presentations 1 1:50 – 12:50 – Chairs: Benedetta Terziroli Beretta -Piccoli and Pietro Invernizzi 11:50 – 12:05 Oral presentation 1 12:05 – 12:20 Oral presentation 2 12:20 – 12:35 Oral presentation 3 12: 35 – 12:50 Oral presentation 4 12: 50-13: 50 Lunch 4 3. Pediatrics 13: 50- 14: 50 – Chairs: Giorgina Mieli -Vergani and Gideon Hirs chfield 13: 50 – 14:05 Case presentation – Christiane Sokollik 14:05 – 14: 25 Sclerosing cholangitis in pediatric IBD patients – Patrick van Rheenen 14: 25 – 14: 45 Growing up with autoimmune liver disease : l ongterm outcome of autoimmune liver disease – Marianne Samyn 14: 45 – 15:05 Discussion 15:05 – 15: 30 Coffee break 4. Checkpoint -inhibitors and the liver 15: 30 – 17:00 – Ansgar Lohse and Maria Isabel Lucena 15: 30 – 15: 45 Clinical case presentation – Antonio Galante 15: 45 – 16:05 Checkpoint -inhibitors -induced liver injury – Eleonora de Martin 16:0 5 – 16: 25 Liver histology of checkpoint -inhibitors -induced liver injury – Yoh Zen 16: 25 – 16: 45 Can checkpoint inhibitors be used in patients with autoimmune liver diseases? – Michael Manns 16: 45 – 17:00 Discussion 17:00 -17: 20 Concluding remarques Benedetta Terziroli Beretta -Piccoli Andreas Kremer Carina Bobzin Robert Mitchell -Thain 17: 20 End of the 4th Swiss AILD Meeting Scientific committe e: 5 Benedetta Terziroli Beretta -Piccoli – Chair Andrea Cerny Andrea De Gottardi Diego Vergani Giorgina Mieli -Vergani Andreas Kremer Federica Sallusto Durchführungsort: USI Università della Svizzera italiana, 6900 Lugano